Acute Promyelocytic Leukemia Unknown Status Phase 4 Trials for Cytarabine (DB00987)

Also known as: Leukaemia (Acute Promyelocytic) / Promyelocytic Leukemia, Acute / Leukemia, Promyelocytic, Acute / Acute Promyelocytic Leukemia (APL) / Acute promyelocytic leukaemia / Acute promyelocytic leukemia with failed remission / Disorder: Acute promyelocytic leukemia, FAB M3 (disorder) / Acute promyelocytic leukemia (morphologic abnormality) / AML M3

DBCOND0036178 (Acute Promyelocytic Leukemia)Unknown Status4 IdentifierTitlePurposeDrugs
NCT01987297Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APLTreatment
NCT00180128AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic LeukemiaPrevention